Aimei Li

2.3k total citations · 1 hit paper
73 papers, 1.8k citations indexed

About

Aimei Li is a scholar working on Molecular Biology, Epidemiology and Nephrology. According to data from OpenAlex, Aimei Li has authored 73 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 15 papers in Epidemiology and 14 papers in Nephrology. Recurrent topics in Aimei Li's work include Chronic Kidney Disease and Diabetes (8 papers), MicroRNA in disease regulation (7 papers) and Dialysis and Renal Disease Management (6 papers). Aimei Li is often cited by papers focused on Chronic Kidney Disease and Diabetes (8 papers), MicroRNA in disease regulation (7 papers) and Dialysis and Renal Disease Management (6 papers). Aimei Li collaborates with scholars based in China, United States and Kenya. Aimei Li's co-authors include Hao Zhang, Shikun Yang, Guorong Duan, Lude Lu, Xujie Yang, Chunxiang Zhang, Xin Wang, Wei Zhang, Wanhua Guo and Zhi‐Jun Jia and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Journal of Materials Science.

In The Last Decade

Aimei Li

68 papers receiving 1.7k citations

Hit Papers

AMPK agonist alleviate renal tubulointerstitial fibrosis ... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. AMPK agonist alleviate renal tubulointerstitial fibrosis via activating mitophagy in high fat and streptozotocin induced diabetic mice
    2021 163 citations Aimei Li, Ming Zhan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aimei Li China 21 664 255 245 229 192 73 1.8k
Jing Ji China 28 1.0k 1.5× 226 0.9× 176 0.7× 83 0.4× 200 1.0× 126 2.2k
Pingping Ren China 26 787 1.2× 156 0.6× 166 0.7× 173 0.8× 246 1.3× 73 2.2k
Jialu Liu China 27 1.1k 1.6× 156 0.6× 270 1.1× 676 3.0× 426 2.2× 178 2.8k
Yumeng Zhang China 23 635 1.0× 96 0.4× 153 0.6× 85 0.4× 128 0.7× 170 2.2k
Jung‐Hoon Kim South Korea 28 1.0k 1.5× 101 0.4× 174 0.7× 81 0.4× 173 0.9× 168 2.6k
Bo Hu China 21 807 1.2× 108 0.4× 103 0.4× 155 0.7× 208 1.1× 80 1.5k
Meng Zhao China 29 1.7k 2.6× 348 1.4× 230 0.9× 321 1.4× 362 1.9× 81 3.2k
Hiroki Tsukamoto Japan 29 1.0k 1.6× 126 0.5× 147 0.6× 133 0.6× 364 1.9× 102 2.5k
Xiaohui Li China 30 898 1.4× 287 1.1× 157 0.6× 53 0.2× 270 1.4× 134 2.7k

Countries citing papers authored by Aimei Li

Since Specialization
Citations

This map shows the geographic impact of Aimei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aimei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aimei Li more than expected).

Fields of papers citing papers by Aimei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aimei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aimei Li. The network helps show where Aimei Li may publish in the future.

Co-authorship network of co-authors of Aimei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Aimei Li. A scholar is included among the top collaborators of Aimei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aimei Li. Aimei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yi, Bin, et al.. (2025). ESCRT III-mediated lysosomal repair improve renal tubular cell injury in cisplatin-induced AKI. Autophagy. 21(9). 1927–1944. 2 indexed citations
2.
Tang, Shiqi, Shikun Yang, Aimei Li, et al.. (2024). Paricalcitol ameliorates diabetic nephropathy by promoting EETs and M2 macrophage polarization and inhibiting inflammation by regulating VDR / CYP2J2 axis. The FASEB Journal. 38(20). e70108–e70108. 3 indexed citations
3.
Zhang, Liuxue, Cong Liu, Xu Jia, et al.. (2023). Titanium‐based MOFs‐derived Cabon‐supported Photocatalysts for the Efficient Degradation of Tetracycline. ChemistrySelect. 8(37). 3 indexed citations
4.
5.
Li, Aimei, Wei Zhang, Xueqin Wu, et al.. (2022). ATP-citrate lyase inhibitor improves ectopic lipid accumulation in the kidney in a db/db mouse model. Frontiers in Endocrinology. 13. 914865–914865. 9 indexed citations
6.
Lu, Changchang, Hao Cheng, Weiwei Kong, et al.. (2022). Case Report: Pathologic Complete Response to Induction Therapy in a Patient With Potentially Resectable Pancreatic Cancer. Frontiers in Oncology. 12. 898119–898119.
7.
Li, Aimei, et al.. (2021). HRD1 attenuates the high uptake of [18F]FDG in hepatocellular carcinoma PET imaging. Nuclear Medicine and Biology. 96-97. 27–34. 7 indexed citations
8.
Liu, Yan, Li Liu, Bin Yi, et al.. (2019). Activation of vitamin D receptor attenuates high glucose-induced cellular injury partially dependent on CYP2J5 in murine renal tubule epithelial cell. Life Sciences. 234. 116755–116755. 8 indexed citations
9.
Yang, Xiaolan, et al.. (2019). The contribution of miR-122 to the innate immunity by regulating toll-like receptor 4 in hepatoma cells. BMC Gastroenterology. 19(1). 130–130. 24 indexed citations
10.
Li, Aimei, et al.. (2019). <p>An efficient and long-acting local anesthetic: ropivacaine-loaded lipid-polymer hybrid nanoparticles for the control of pain</p>. International Journal of Nanomedicine. Volume 14. 913–920. 35 indexed citations
11.
12.
Li, Aimei, Wei Zhang, Hao Zhang, & Bin Yi. (2017). [Vitamin D/vitamin D receptor, autophagy and inflammation relevant diseases].. PubMed. 42(8). 979–985. 6 indexed citations
13.
14.
Zhai, Aixia, Jun Qian, Aimei Li, et al.. (2015). Down-regulation of suppressor of cytokine signaling 3 by miR-122 enhances interferon-mediated suppression of hepatitis B virus. Antiviral Research. 118. 20–28. 29 indexed citations
15.
Li, Aimei, Zhi‐Jun Jia, Hangyu Li, et al.. (2015). Ganoderma lucidum polysaccharide extract inhibits hepatocellular carcinoma growth by downregulating regulatory T cells accumulation and function by inducing microRNA-125b. Journal of Translational Medicine. 13(1). 100–100. 92 indexed citations
16.
Ren, Wei, Feng Jiang, Jun Lü, et al.. (2014). CCAAT/Enhancer-Binding ProteinαIs a Crucial Regulator of Human Fat Mass and Obesity Associated Gene Transcription and Expression. BioMed Research International. 2014. 1–7. 22 indexed citations
17.
Guo, Wanhua, et al.. (2013). Transferrin modified PEG-PLA-resveratrol conjugates: In vitro and in vivo studies for glioma. European Journal of Pharmacology. 718(1-3). 41–47. 95 indexed citations
18.
Li, Hongxiu, Zhi‐Jun Jia, Aimei Li, et al.. (2013). Resveratrol repressed viability of U251 cells by miR-21 inhibiting of NF-κB pathway. Molecular and Cellular Biochemistry. 382(1-2). 137–143. 53 indexed citations
19.
Song, Wuqi, Yujun Li, Jun Qian, et al.. (2012). Over-expression of mitochondrial antiviral signaling protein inhibits coxsackievirus B3 infection by enhancing type-I interferons production. Virology Journal. 9(1). 312–312. 11 indexed citations
20.
Duan, Guorong, Chunxiang Zhang, Aimei Li, et al.. (2008). Preparation and Characterization of Mesoporous Zirconia Made by Using a Poly (methyl methacrylate) Template. Nanoscale Research Letters. 3(3). 118–22. 261 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jing Ji Breakdown of academic impact, for papers by Pingping Ren Breakdown of academic impact, for papers by Jialu Liu Breakdown of academic impact, for papers by Yumeng Zhang Breakdown of academic impact, for papers by Jung‐Hoon Kim Breakdown of academic impact, for papers by Bo Hu Breakdown of academic impact, for papers by Meng Zhao Breakdown of academic impact, for papers by Hiroki Tsukamoto Breakdown of academic impact, for papers by Xiaohui Li
Rankless by CCL
2026